Epidermolysis bullosa (EB) is the term given to a group ... Lawrence Schachner, MD, is a Professor of Dermatology and Pediatrics, and Director, Division of Pediatric Dermatology, University ...

FDA grants CORDStrom a Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) for treatment of epidermolysis bullosa (EB). Parallel efforts will seek marketing authorizations ...

a therapy for the treatment of recessive dystrophic epidermolysis bullosa (RDEB) in pediatric patients. According to InvestingPro data, the company maintains a strong financial position with more ...

Carol Schober-Flores, BSN, RN, is a Mohs Surgical Nurse and Epidermolysis Bullosa Nurse Specialist, University Hospital, Denver, CO. Topical ointments can be applied directly over the Mepitel ...

Initial pediatric subject shows sustained benefit with QRX003; second patient approved for full-body treatment in ongoing ...

The company announced plans to submit regulatory filings for CORDStrom, a therapy for the treatment of recessive dystrophic epidermolysis bullosa (RDEB) in pediatric patients, following positive ...

and epidermolysis bullosa acquisita. We work in close collaboration with other specialties, including ophthamology, ENT, Ob/Gyn, and gastroenterology to provide comprehensive care of these patients.

The eighth annual Plunge for Elodie will take place on Saturday at Morses Pond in Wellesley to raise money for Epidermolysis bullosa (EB) research. The Plunge for Elodie has raised nearly $3 ...